These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 37930150)

  • 1. Predicting hepatic encephalopathy in patients with cirrhosis: A UK population-based study and validation of risk scores.
    Jones BI; Jenkins CA; Murphy D; Orr J; Yeoman A; Hubbuck ER; Heywood BR; Currie CJ
    Hepatol Commun; 2023 Nov; 7(11):. PubMed ID: 37930150
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A risk score to predict the development of hepatic encephalopathy in a population-based cohort of patients with cirrhosis.
    Tapper EB; Parikh ND; Sengupta N; Mellinger J; Ratz D; Lok AS; Su GL
    Hepatology; 2018 Oct; 68(4):1498-1507. PubMed ID: 29091289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Undiagnosed Cirrhosis and Hepatic Encephalopathy in a National Cohort of Veterans With Dementia.
    Bajaj JS; Silvey SG; Rogal S; O'Leary JG; Patton H; Morgan TR; Kanagalingam G; Gentili A; Godschalk M; Patel N
    JAMA Netw Open; 2024 Jan; 7(1):e2353965. PubMed ID: 38294815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of hepatic encephalopathy in patients with cirrhosis treated with current standards of care.
    Bohra A; Worland T; Hui S; Terbah R; Farrell A; Robertson M
    World J Gastroenterol; 2020 May; 26(18):2221-2231. PubMed ID: 32476788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimal hepatic encephalopathy and critical flicker frequency are associated with survival of patients with cirrhosis.
    Ampuero J; Simón M; Montoliú C; Jover R; Serra MÁ; Córdoba J; Romero-Gómez M
    Gastroenterology; 2015 Nov; 149(6):1483-9. PubMed ID: 26299413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes after hepatic encephalopathy in population-based cohorts of patients with cirrhosis.
    Tapper EB; Aberasturi D; Zhao Z; Hsu CY; Parikh ND
    Aliment Pharmacol Ther; 2020 Jun; 51(12):1397-1405. PubMed ID: 32363684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opioid prescriptions are associated with hepatic encephalopathy in a national cohort of patients with compensated cirrhosis.
    Moon AM; Jiang Y; Rogal SS; Tapper EB; Lieber SR; Barritt AS
    Aliment Pharmacol Ther; 2020 Mar; 51(6):652-660. PubMed ID: 31960985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The psychomotor vigilance task: Role in the diagnosis of hepatic encephalopathy and relationship with driving ability.
    Formentin C; De Rui M; Zoncapè M; Ceccato S; Zarantonello L; Senzolo M; Burra P; Angeli P; Amodio P; Montagnese S
    J Hepatol; 2019 Apr; 70(4):648-657. PubMed ID: 30633946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and Validation of a Prognostic Score to Predict Covert Hepatic Encephalopathy in Patients With Cirrhosis.
    Labenz C; Toenges G; Huber Y; Nagel M; Marquardt JU; Schattenberg JM; Galle PR; Labenz J; Wörns MA
    Am J Gastroenterol; 2019 May; 114(5):764-770. PubMed ID: 30848730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RiMINI - the influence of rifaximin on minimal hepatic encephalopathy (MHE) and on the intestinal microbiome in patients with liver cirrhosis: study protocol for a randomized controlled trial.
    Schulz C; Schütte K; Kropf S; Schmitt FC; Vasapolli R; Kliegis LM; Riegger A; Malfertheiner P
    Trials; 2016 Feb; 17(1):111. PubMed ID: 26926775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Burden of compensated and decompensated cirrhosis: real world data from an Italian population-based cohort study.
    Cammarota S; Citarella A; Bernardi FF; Claar E; Fogliasecca M; Manzo V; Rosato V; Toraldo B; Trama U; Valente A; Conti V
    Eur Rev Med Pharmacol Sci; 2021 Jul; 25(13):4490-4498. PubMed ID: 34286491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of recurrent hepatic encephalopathy in patients with liver cirrhosis: a German registry study.
    Gabriel MM; Kircheis G; Hardtke S; Markwardt D; Buggisch P; Mix H; Grüngreiff K; Welzel TM; Kälsch J; Hartmann H; Gerbes AL; Karpowitz MV; Seeliger B; Wedemeyer H; Weissenborn K;
    Eur J Gastroenterol Hepatol; 2021 Sep; 33(9):1185-1193. PubMed ID: 32658009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Primary prophylaxis of overt hepatic encephalopathy in patients with cirrhosis: an open labeled randomized controlled trial of lactulose versus no lactulose.
    Sharma P; Sharma BC; Agrawal A; Sarin SK
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1329-35. PubMed ID: 22606978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proton Pump Inhibitors Increase Risk for Hepatic Encephalopathy in Patients With Cirrhosis in A Population Study.
    Tsai CF; Chen MH; Wang YP; Chu CJ; Huang YH; Lin HC; Hou MC; Lee FY; Su TP; Lu CL
    Gastroenterology; 2017 Jan; 152(1):134-141. PubMed ID: 27639806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Prevalence, Predictors, and In-Hospital Mortality of Hepatic Encephalopathy in Patients with Liver Cirrhosis Admitted at St. Dominic Hospital in Akwatia, Ghana.
    Duah A; Agyei-Nkansah A; Osei-Poku F; Duah F; Ampofo-Boobi D; Peprah B
    Can J Gastroenterol Hepatol; 2020; 2020():8816522. PubMed ID: 33425806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epilepsy as a risk factor for hepatic encephalopathy in patients with cirrhosis: a cohort study.
    Jepsen P; Christensen J; Weissenborn K; Watson H; Vilstrup H
    BMC Gastroenterol; 2016 Jul; 16(1):77. PubMed ID: 27457247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and validation of a prognosis nomogram for MIMIC-III patients with liver cirrhosis complicated with hepatic encephalopathy.
    Yan W; Yao Z; Ou Q; Ye G
    BMC Gastroenterol; 2023 Sep; 23(1):335. PubMed ID: 37770848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of the AMMON-OHE model to predict risk of overt hepatic encephalopathy occurrence in outpatients with cirrhosis.
    Ballester MP; Tranah TH; Balcar L; Fiorillo A; Ampuero J; Kerbert AJC; Thomsen KL; Escudero MD; Mandorfer M; Reiberger T; Shawcross DL; Romero-Gómez M; Montoliu C; Carbonell-Asins JA; Jalan R
    J Hepatol; 2023 Oct; 79(4):967-976. PubMed ID: 37277075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic Encephalopathy Is Associated with Persistent Learning Impairments Despite Adequate Medical Treatment: A Multicenter, International Study.
    Nardelli S; Allampati S; Riggio O; Mullen KD; Prakash R; Gioia S; Unser A; White MB; Fagan AC; Wade JB; Farcomeni A; Gavis EA; Bajaj JS
    Dig Dis Sci; 2017 Mar; 62(3):794-800. PubMed ID: 28039670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcome Prediction of Covert Hepatic Encephalopathy in Liver Cirrhosis: Comparison of Four Testing Strategies.
    Labenz C; Toenges G; Schattenberg JM; Nagel M; Huber Y; Marquardt JU; Labenz J; Galle PR; Wörns MA
    Clin Transl Gastroenterol; 2020 Jun; 11(6):e00172. PubMed ID: 32568474
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.